Paper
14 August 1992 Excimer laser photorefractive keratectomy for myopia: preliminary results at one year
Keith P. Thompson M.D., George O. Waring III, Roger Steinert M.D., Daniel S. Durrie M.D., Michael Gordon M.D., Stephen F. Brint M.D.
Author Affiliations +
Proceedings Volume 1644, Ophthalmic Technologies II; (1992) https://doi.org/10.1117/12.137425
Event: OE/LASE '92, 1992, Los Angeles, CA, United States
Abstract
Excimer laser photorefractive keratectomy (PRK) is presently under investigation for the correction of myopia. Two companies in the United States, Summit Technology (Waltham, Mass.) and VisX, Inc. (Sunnyvale, Calif.) have developed excimer laser delivery systems and are participating in an FDA study to determine the safety and efficacy of PRK. This is a preliminary report on the refractive and visual results of 51 of 100 eyes treated between October 10, 1990 and March 7, 1991 by the Summit Technology UV200LA excimer laser under the FDA Phase IIB FDA protocol one year after surgery. More detailed information on eight patients treated at Emory University Eye Center (Emory Subgroup) is also reported.
© (1992) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Keith P. Thompson M.D., George O. Waring III, Roger Steinert M.D., Daniel S. Durrie M.D., Michael Gordon M.D., and Stephen F. Brint M.D. "Excimer laser photorefractive keratectomy for myopia: preliminary results at one year", Proc. SPIE 1644, Ophthalmic Technologies II, (14 August 1992); https://doi.org/10.1117/12.137425
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Excimer lasers

Surgery

Visualization

Eye

Cornea

Laser ablation

Laser therapeutics

RELATED CONTENT


Back to Top